Age (years) |
60.4 ± 11.05 |
54.6 ± 11.9 |
58 ± 11.7 |
0.013 |
0.533 |
Male, n (%) |
20 (33.3) |
21 (50) |
41 (40.2) |
0.091 |
|
Duration of diabetes (years) |
8.1 ± 6.9 |
6.5 ± 4.8 |
7.4 ± 6.2 |
0.175 |
|
Glycated haemoglobin (%) |
7.8 ± 2.6 |
6.6 ± 2.2 |
7.3 ± 2.5 |
0.063 |
|
Microvascular complications, n (%) |
18 (30) |
11 (26.2) |
29 (28.4) |
0.824 |
|
Macrovascular complications
n (%)
|
3 (5)
|
2 (4.8)
|
5 (4.9)
|
0.956
|
|
Hypertension, n (%) |
40 (66.7) |
21 (50) |
61 (59.8) |
0.091 |
|
Chronic kidney disease,
n (%)
|
3 (5)
|
0 (0)
|
3 (2.9)
|
0.266
|
|
Dyslipidemia, n (%) |
13 (21.7) |
4 (9.5) |
17 (16.7) |
0.105 |
|
Total cholesterol level (g/l) |
1.8 ± 0.5 |
1.6 ± 0.3 |
1.7 ± 0.5 |
0.208 |
|
Duration of HTN, (years) |
7.4 ± 5.7 |
8.6 ± 6.4 |
7.8 ± 5.9 |
0.430 |
|
Oral antidiabetics, n (%) |
47 (78.3) |
32 (76.2) |
79 (77.5) |
0.799 |
|
Insulin, n (%) |
17 (28.3) |
12 (28.6) |
29 (28.4) |
0.979 |
|
ACEi/ARA, n (%) |
24 (40) |
11 (26.2) |
35 (34.3) |
0.148 |
|
Statin, n (%) |
11 (18.3) |
5 (11.9) |
16 (15.7) |
0.380 |
|
SBP (mmHg) |
144.5 ± 21.8 |
135.2 ± 21.1 |
140.6 ± 21.9 |
0.034 |
0.937 |
DBP (mmHg) |
88.3 ± 12.2 |
85.2 ± 11.5 |
87 ± 11.9 |
0.211 |
|
Heart rate (bpm) |
75.2 ± 12.5 |
79.2 ± 12.4 |
76.9 ± 12.6 |
0.111 |
|
BMI (Kg/m²) |
30.1 ± 6.04 |
27.1 ± 4.4 |
28.9 ± 5.6 |
0.007 |
0.022 |